Expression of metalloproteinases 2 and 9 and cyclooxygenase 2 in endometrial carcinoma

International Journal of Gynecology and Obstetrics

Volumn 93, Issue 1, 2006, Pages 64-66

  Raspollini, M R ^a   Susini, T ^a   Taddei, G L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cyclo oxygenase 2; Endometrial carcinoma; Metalloproteinase 2; Metalloproteinase 9; Reverse transcriptase polymerase chain reaction

Indexed keywords

CYCLOOXYGENASE 2; METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; EXTRACELLULAR MATRIX; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOMODULATION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 33645950085     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2005.12.028     Document Type: Article

References (4)

1. Chaffer C.L., Dopheide B., McCulloch D.R., et al. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22 (2005) 115-125
2. Ryan E.P., Pollok S.J., Murant T.I., et al. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J Immunol 174 (2005) 2619-2626
3. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxigenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
4. Yamaguchi N.H., Lichtengels A.J., Demarchi L., et al. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung: a study of 117 patients from Brazil. Am J Clin Pathol 121 (2004) 78-86